Baxter International Q3 Earnings Report Highlights Higher Sales Performance
Friday, 8 November 2024, 14:41
Baxter International Reports Strong Q3 Earnings
In the latest financial disclosure, Baxter International Inc. (NYSE: BAX) reported earnings for the third quarter of 2024, showcasing significant growth in sales. The financial results demonstrate a commitment to excellence in the medical devices sector.
Sales Performance Overview
- Sales from continuing operations stood at $2.70 billion.
- Total third-quarter worldwide sales reached $3.85 billion.
- Sales from discontinued operations contributed $1.15 billion.
Financial Impact and Earnings Analysis
While Baxter's net income decreased to $140 million from $2.51 billion year-over-year, the adjusted earnings were reported at $0.80 per share. This reflects a slight decline from $0.82 per share in the same quarter last year.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.